Delivery Order SPE2DB24D2216-SPE2DB25FGNBW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,068.03 firm fixed-price delivery order is for the supply of PROGESTERONE 100 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,224.80 firm fixed-price delivery order is for the supply of PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through May 20, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.73, is for the delivery of 4567222881 ! PROGESTERONE 200 MG CAPSULE 30S. It is a firm fixed-price delivery order contract with a period of performance through February 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567074556 PROGESTERONE 200 MG CAPSULE 100S. The firm-fixed-price delivery order, valued at $8,186.76, has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $4,719.07, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of PROGESTERONE 200 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $9,416.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through March 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $13,415.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567300692 PROGESTERONE 200 MG CAPSULE 100S, with an ultimate completion date of February 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567537329 - PROGESTERONE 200 MG CAPSULE 100S, with a ceiling value of $6,603.31 and a period of performance through March 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPJ14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,172.54 firm fixed-price delivery order is for the supply of 4567117594 ! PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $9,415.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROGESTERONE 200 MG CAPSULE 100S medical supplies, with a completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNBWDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,314.92 firm fixed-price delivery order is for the supply of 4567556790 ! PROGESTERONE 200 MG CAPSULE 100S, with a period of performance through March 12, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.3k | 3/11/25 |